Improving nerve repair techniques for better recovery from injuries
Official title: Translating Novel Peripheral Nerve Allograft Technologies Toward Clinical Use
Funded at University of Texas at Austin · NIH-11088762 · Data updated 2026-11-12
This study is exploring new ways to help people recover from nerve injuries by using special nerve grafts and treatments that can speed up healing, so patients can get back to feeling normal faster.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $608,885 |
| NIH project number | 5R01NS128086-03 |
| Project ID | NIH-11088762 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have suffered from peripheral nerve injuries resulting in significant nerve gaps.
✕Less likely to help
Patients with complete nerve transections or those who do not have peripheral nerve injuries may not benefit from this research.
What this research studies
This research focuses on enhancing the repair of peripheral nerve injuries (PNIs) that result in nerve gaps. The team is developing innovative techniques that involve using viable peripheral nerve allografts combined with localized immunosuppression and polyethylene-induced axon fusion. This approach aims to restore nerve function more quickly and effectively than current methods, which often lead to slow recovery. By preventing nerve degeneration and promoting faster re-innervation, this research seeks to improve patient outcomes significantly.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective recovery from nerve injuries, reducing long-term disability for patients.
How similar studies have gone: Previous research has shown promise in using similar techniques for nerve repair, indicating potential for success in this novel approach.
Where this research is happening
-
University of Texas at Austin
Austin, United States Active
Researchers
- Principal investigator: Bittner, George Davis — University of Texas at Austin
- Study coordinator: Bittner, George Davis
Related research
Other NIH-funded projects on the same topics.
-
Translating new nerve grafts to clinical use
Aims to bring advanced nerve graft technology that uses PEG-fusion and localized immunosuppression to patients with nerve gaps.
-
GABA-A receptor gating mechanisms and how drugs affect them
Researchers are studying how GABA-A receptor gates work and how medicines can modulate them to help people with epilepsy, Alzheimer's-related symptoms, and other brain disorders.
-
Nanoparticles that calm inflammation after artery procedures
A new nanoparticle inspired by dying cells is being tested to reduce inflammation after artery procedures and help PAD patients heal better.
-
Silent speech interface using a wearable tongue tracker to help people after laryngectomy communicate
A wearable system with tongue sensors and intraoral components aims to let people without a vocal cord use natural-sounding speech in daily life.
-
Understanding and reversing abnormal brain activity in Alzheimer's disease
Aims to understand how unusual brain activity contributes to Alzheimer’s and test ways to reverse it to help people with the condition.
-
CFDE Cloud Workspace to help researchers share and analyze data
A cloud-based workspace will let a wide range of researchers import, integrate, and analyze data from CFDE and other sources using familiar tools and workflows.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.